October 9, 2017
ThromboGenics publishes data on Diabetic Retinopathy possible therapy
ThromboGenics’s preclinical data on its THR-317 have been published in Experimental Eye Research, the company said on Monday.
Pharmaceuticals, Biotechnology and Life Sciences
ThromboGenics’s preclinical data on its THR-317 have been published in Experimental Eye Research, the company said on Monday.